Table 3.
Outcome by per‐protocol analysis
| RIPC group | Control group | ||
|---|---|---|---|
| (n = 72) | (n = 70) | P * | |
| Myocardial infarction | 26 (36) | 30 (43) | 0·502 |
| 30‐day mortality | 14 (19) | 24 (34) | 0·035 |
| Cause of death | |||
| Cardiac | 2 | 4 | |
| Multiple organ failure | 3 | 7 | |
| Intestinal ischaemia | 2 | 7 | |
| Pulmonary | 1 | 3 | |
| Bleeding | 4 | 1 | |
| Renal | 2 | 1 | |
| Infection | 0 | 1 | |
| Multiple organ failure | 10 (14) | 11 (16) | 0·472 |
| Intestinal ischaemia | 5 (7) | 12 (17) | 0·052 |
| Dialysis | 14 (19) | 17 (24) | 0·310 |
| Stroke | 2 (3) | 2 (3) | 0·679 |
Values in parentheses are percentages. RIPC, remote ischaemic preconditioning.
*
Fisher's exact test.